MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, X. F.
Right arrow Articles by Chen, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, X. F.
Right arrow Articles by Chen, S. A.

Reaction of rat liver DT-diaphorase (NAD(P)H:quinone acceptor reductase) with 5'-[p-(fluorosulfonyl)benzoyl]-adenosine

XF Liu, H Yuan, M Haniu, T Iyanagi, JE Shively and SA Chen

Division of Immunology, Beckman Research Institute of the City of Hope, Duarte, California 91010.

Rat liver DT-diaphorase is inactivated by 5'-[p- (fluorosulfonyl)benzoyl]adenosine (5'-FSBA), following pseudo-first- order kinetics. A double-reciprocal plot of 1/kobs versus 1/[5'-FSBA] yields a straight line with a positive y intercept, indicative of reversible binding of the inhibitor before an irreversible incorporation. The dissociation constant (Kd) for the initial reversible enzyme-inhibitor complex is estimated at 2.86 mM with k2 = 0.22 min-1 (at pH 7.5 and 25 degrees). A stoichiometry of 2 mol of 5'- FSBA bound/mol of enzyme (i.e., 1 mol of the inhibitor bound/mol of subunit), at 100% inactivation, was determined from inactivation kinetics and from incorporation studies using 5'-[p- (fluorosulfonyl)benzoyl]-[14C]-adenosine. The irreversible inactivation as well as the covalent incorporation could be completely prevented by the presence of NAD(P)H during the incubation. These results indicate that 5'-FSBA inactivated DT-diaphorase by occupying its NAD(P)H binding site. Reverse phase high pressure liquid chromatography of tryptic digests of [14C]5'-FSBA-labeled DT-diaphorase revealed one radioactive peak containing two comigrating peptides. They are 146I-T-T-G-G-S-G-S-M- Y155 and 262S-I-P-A-D-N-Q-I-K270. By comparison of these sequences to those of the nucleotide binding sites of several kinases and dehydrogenases, it is suggested that the peptide I-T-T-G-G-S-G-S-M-Y is the one modified by 5'-FSBA and would be predicted to be the region where the pyrophosphate group of NAD(P)H binds.

Volume 35, Issue 6, pp. 818-822, 06/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Protein Sci.Home page
I. I. Vorontsov, G. Minasov, J. S. Brunzelle, L. Shuvalova, O. Kiryukhina, F. R. Collart, and W. F. Anderson
Crystal structure of an apo form of Shigella flexneri ArsH protein with an NADPH-dependent FMN reductase activity
Protein Sci., November 1, 2007; 16(11): 2483 - 2490.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Tedeschi, S. Chen, and V. Massey
Active Site Studies of DT-diaphorase Employing Artificial Flavins
J. Biol. Chem., February 10, 1995; 270(6): 2512 - 2516.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1989 by the American Society for Pharmacology and Experimental Therapeutics